Milton, MA, United States of America

Mark Wood

This inventor holds 1 USPTO granted patent. Top assignees: Baylor University, Oxigene, Inc.. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark Wood. Retrieved from https://idiyas.com/inventor/mark-wood-s0wsqxv2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mark Wood: Innovator in Therapeutic Compositions

Introduction

Mark Wood is a notable inventor based in Milton, MA (US). He has made significant contributions to the field of therapeutic compositions, particularly in the treatment of solid tumor cancers and vascular proliferative disorders. His innovative work has the potential to enhance anti-tumor responses in patients.

Latest Patents

Mark Wood holds 1 patent for his invention titled "Compositions and methods with enhanced therapeutic activity." This patent focuses on novel quinone and catechol compositions, including prodrugs of these compounds. The methods described in his patent aim to generate both a vascular targeting effect and direct tumor cell cytotoxicity, thereby achieving an improved anti-tumor response.

Career Highlights

Throughout his career, Mark Wood has worked with various organizations, including Oxigene, Inc. and Baylor University. His experience in these institutions has allowed him to develop and refine his innovative ideas in therapeutic compositions.

Collaborations

Mark has collaborated with notable individuals in his field, including David J Chaplin and Klaus Edvardsen. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Mark Wood's contributions to the field of therapeutic compositions demonstrate his commitment to improving cancer treatment methodologies. His innovative approaches have the potential to significantly impact patient care and outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…